This product has the characteristics of promoting mucus elimination and dissolving secretions, which can promote the elimination of viscous secretions in the respiratory tract and reduce mucus retention, significantly promote expectoration, and improve respiratory conditions. When using this product for treatment, the patient's mucus secretion can be restored to normal, coughing and sputum volume are usually significantly reduced, and the surfactant on the respiratory mucosa can thus play its normal protective function.

It has the effect of competitively blocking the binding of histamine to H2 receptors. Its inhibitory effect on gastric acid is 5 to 12 times that of cimetidine in terms of moles. Therefore, it is a potent H2 receptor blocker.

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. Poor antibacterial activity against anaerobic bacteria. Ofloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

Supplement calories, treat hypoglycemia, treat hyperkalemia when used with insulin, hypertonic glucose injection has tissue dehydration effect

Glucose is one of the main sources of heat for the human body. Each gram of glucose can produce 4 calories (16.7 kJ) of heat energy, so it is used to supplement heat. Treat hypoglycemia. When glucose and insulin are intravenously infused together, the synthesis of glycogen requires the participation of potassium ions, so potassium ions enter the cells and the blood potassium concentration decreases, so it is used to treat hyperkalemia. Rapid intravenous injection of hypertonic glucose injection has a tissue dehydrating effect and can be used as a tissue dehydrating agent. In addition, glucose is the main substance for maintaining and regulating the osmotic pressure of peritoneal dialysis fluid.

Maintain electrolyte balance in the body